OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
Yinghui Liu, Gaowei Hu, Yuyan Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 12
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 518

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449

Comparison of nonhuman primates identified the suitable model for COVID-19
Shuaiyao Lu, Yuan Zhao, Wenhai Yu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 224

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
Carina Conceicao, Nazia Thakur, Stacey Human, et al.
PLoS Biology (2020) Vol. 18, Iss. 12, pp. e3001016-e3001016
Open Access | Times Cited: 201

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
Chenxi Li, Chengxue Zhao, Jingfeng Bao, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 35-46
Open Access | Times Cited: 149

Assessing the risks of SARS-CoV-2 in wildlife
Richard J. Delahay, José de la Fuente, Graham Smith, et al.
One Health Outlook (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 114

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
Shuyuan Zhang, Shuyuan Qiao, Jinfang Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 112

SARS-CoV-2 infection and transmission in the North American deer mouse
Bryan D. Griffin, Mable Chan, Nikesh Tailor, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 109

Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108

Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1572-1587.e11
Open Access | Times Cited: 89

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Baoling Ying, Bradley Whitener, Laura A. VanBlargan, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 630
Open Access | Times Cited: 69

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
Ningke Hou, Lei Shuai, Lijing Zhang, et al.
ACS Central Science (2023) Vol. 9, Iss. 2, pp. 217-227
Open Access | Times Cited: 60

The Potential Intermediate Hosts for SARS-CoV-2
Jie Zhao, Wei Cui, Baoping Tian
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 133

SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals
Su Datt Lam, Nicola Bordin, Vaishali Waman, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 121

Risk of human‐to‐wildlife transmission of SARS‐CoV‐2
Sophie Gryseels, Luc De Bruyn, Ralf Gyselings, et al.
Mammal Review (2020) Vol. 51, Iss. 2, pp. 272-292
Open Access | Times Cited: 98

COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans
Roger Frutos, Jordi Serra‐Cobo, Tianmu Chen, et al.
Infection Genetics and Evolution (2020) Vol. 84, pp. 104493-104493
Open Access | Times Cited: 88

Are Animals a Neglected Transmission Route of SARS-CoV-2?
Marta Hernández, David Abad, José María Eirós Bouza, et al.
Pathogens (2020) Vol. 9, Iss. 6, pp. 480-480
Open Access | Times Cited: 76

Monitoring of SARS‐CoV‐2 infection in mustelids
Anette Boklund, Christian Gortázar, Paolo Pasquali, et al.
EFSA Journal (2021) Vol. 19, Iss. 3
Open Access | Times Cited: 76

Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2
Ilya R. Fischhoff, Adrian A. Castellanos, João Rodrigues, et al.
Proceedings of the Royal Society B Biological Sciences (2021) Vol. 288, Iss. 1963
Open Access | Times Cited: 76

An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 72

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
Ting Pan, Ran Chen, Xin He, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 71

Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
Sachiko Koyama, Kenji Kondo, Rumi Ueha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8912-8912
Open Access | Times Cited: 62

Page 1 - Next Page

Scroll to top